NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 50 filers reported holding NEURODERM LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $344,000 | -47.9% | 11,500 | -53.8% | 0.04% | -36.9% |
| Q1 2017 | $660,000 | -73.2% | 24,876 | -77.6% | 0.06% | -68.4% |
| Q4 2016 | $2,462,000 | +19.2% | 110,896 | -0.7% | 0.21% | +4.6% |
| Q3 2016 | $2,065,000 | +14.7% | 111,696 | +0.8% | 0.20% | -20.6% |
| Q2 2016 | $1,800,000 | +32.9% | 110,784 | +15.5% | 0.25% | +34.1% |
| Q1 2016 | $1,354,000 | +67.4% | 95,924 | +102.1% | 0.18% | +79.6% |
| Q4 2015 | $809,000 | +114.0% | 47,471 | +159.3% | 0.10% | +71.7% |
| Q3 2015 | $378,000 | – | 18,310 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |